NEO
Price
$6.25
Change
+$0.04 (+0.64%)
Updated
Aug 18, 03:48 PM (EDT)
Capitalization
802.2M
85 days until earnings call
VCYT
Price
$30.27
Change
+$0.05 (+0.17%)
Updated
Aug 18, 04:13 PM (EDT)
Capitalization
2.38B
85 days until earnings call
Interact to see
Advertisement

NEO vs VCYT

Header iconNEO vs VCYT Comparison
Open Charts NEO vs VCYTBanner chart's image
NeoGenomics
Price$6.25
Change+$0.04 (+0.64%)
Volume$564
Capitalization802.2M
Veracyte
Price$30.27
Change+$0.05 (+0.17%)
Volume$680
Capitalization2.38B
NEO vs VCYT Comparison Chart in %
Loading...
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NEO vs. VCYT commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEO is a Hold and VCYT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (NEO: $6.21 vs. VCYT: $30.04)
Brand notoriety: NEO and VCYT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NEO: 73% vs. VCYT: 0%
Market capitalization -- NEO: $802.2M vs. VCYT: $2.38B
NEO [@Medical Specialties] is valued at $802.2M. VCYT’s [@Medical Specialties] market capitalization is $2.38B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $10.48B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEO’s FA Score shows that 0 FA rating(s) are green whileVCYT’s FA Score has 0 green FA rating(s).

  • NEO’s FA Score: 0 green, 5 red.
  • VCYT’s FA Score: 0 green, 5 red.
According to our system of comparison, both NEO and VCYT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEO’s TA Score shows that 5 TA indicator(s) are bullish while VCYT’s TA Score has 6 bullish TA indicator(s).

  • NEO’s TA Score: 5 bullish, 3 bearish.
  • VCYT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both NEO and VCYT are a good buy in the short-term.

Price Growth

NEO (@Medical Specialties) experienced а +7.07% price change this week, while VCYT (@Medical Specialties) price change was +9.76% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +4.05%. For the same industry, the average monthly price growth was +15.46%, and the average quarterly price growth was +0.41%.

Reported Earning Dates

NEO is expected to report earnings on Nov 11, 2025.

VCYT is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Medical Specialties (+4.05% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VCYT($2.38B) has a higher market cap than NEO($802M). VCYT YTD gains are higher at: -24.141 vs. NEO (-62.318). VCYT has higher annual earnings (EBITDA): 53.8M vs. NEO (-28.47M). VCYT has more cash in the bank: 287M vs. NEO (164M). VCYT has less debt than NEO: VCYT (50.5M) vs NEO (412M). NEO has higher revenues than VCYT: NEO (689M) vs VCYT (463M).
NEOVCYTNEO / VCYT
Capitalization802M2.38B34%
EBITDA-28.47M53.8M-53%
Gain YTD-62.318-24.141258%
P/E RatioN/A88.88-
Revenue689M463M149%
Total Cash164M287M57%
Total Debt412M50.5M816%
FUNDAMENTALS RATINGS
NEO vs VCYT: Fundamental Ratings
NEO
VCYT
OUTLOOK RATING
1..100
507
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
71
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9488
PRICE GROWTH RATING
1..100
9152
P/E GROWTH RATING
1..100
10075
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NEO's Valuation (63) in the Medical Or Nursing Services industry is in the same range as VCYT (71) in the Biotechnology industry. This means that NEO’s stock grew similarly to VCYT’s over the last 12 months.

NEO's Profit vs Risk Rating (100) in the Medical Or Nursing Services industry is in the same range as VCYT (100) in the Biotechnology industry. This means that NEO’s stock grew similarly to VCYT’s over the last 12 months.

VCYT's SMR Rating (88) in the Biotechnology industry is in the same range as NEO (94) in the Medical Or Nursing Services industry. This means that VCYT’s stock grew similarly to NEO’s over the last 12 months.

VCYT's Price Growth Rating (52) in the Biotechnology industry is somewhat better than the same rating for NEO (91) in the Medical Or Nursing Services industry. This means that VCYT’s stock grew somewhat faster than NEO’s over the last 12 months.

VCYT's P/E Growth Rating (75) in the Biotechnology industry is in the same range as NEO (100) in the Medical Or Nursing Services industry. This means that VCYT’s stock grew similarly to NEO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NEOVCYT
RSI
ODDS (%)
Bullish Trend 4 days ago
66%
Bearish Trend 4 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
73%
Bearish Trend 4 days ago
89%
Momentum
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 4 days ago
80%
MACD
ODDS (%)
Bullish Trend 4 days ago
68%
Bullish Trend 4 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 4 days ago
79%
Advances
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 6 days ago
73%
Declines
ODDS (%)
Bearish Trend 13 days ago
83%
Bearish Trend 19 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
70%
Bearish Trend 4 days ago
85%
Aroon
ODDS (%)
Bearish Trend 4 days ago
80%
Bullish Trend 4 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MKVIX16.960.11
+0.65%
MFS International Large Cap Value I
DQEIX13.290.03
+0.23%
BNY Mellon Global Equity Income - I
HFEAX58.20-0.01
-0.02%
Janus Henderson European Focus A
EMCCX55.64-0.11
-0.20%
Empiric Class C
HCMZX20.41-0.10
-0.49%
HCM Sector Plus R

NEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEO has been loosely correlated with RGEN. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if NEO jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEO
1D Price
Change %
NEO100%
+0.16%
RGEN - NEO
38%
Loosely correlated
-1.81%
VCYT - NEO
38%
Loosely correlated
N/A
FLGT - NEO
38%
Loosely correlated
-2.21%
TWST - NEO
36%
Loosely correlated
-2.50%
NNOX - NEO
36%
Loosely correlated
-1.78%
More

VCYT and

Correlation & Price change

A.I.dvisor indicates that over the last year, VCYT has been loosely correlated with GH. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if VCYT jumps, then GH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCYT
1D Price
Change %
VCYT100%
N/A
GH - VCYT
53%
Loosely correlated
-2.45%
NTRA - VCYT
53%
Loosely correlated
+2.89%
TWST - VCYT
52%
Loosely correlated
-2.50%
RVTY - VCYT
47%
Loosely correlated
+1.49%
INGN - VCYT
47%
Loosely correlated
-2.74%
More